Enteropathy-type T-cell lymphoma after intestinal diffuse large B-cell lymphoma

American Journal of Surgical Pathology

Volumn 31, Issue 3, 2007, Pages 476-480

  Nava, Victor E ^a,b   Cohen, Philip ^a   Bishop, Michael ^c   Fowler, Daniel ^c   Jaffe, Elaine S ^c   Ozdemirli, Metin ^a  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

B cell; Celiac disease; Enteropathy; Lymphoma; T cell

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DOXORUBICIN; ETOPOSIDE; FAMCICLOVIR; FLUDARABINE; LAMIVUDINE; PREDNISONE; VINCRISTINE; TUMOR MARKER;

ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; B CELL LYMPHOMA; BRAIN DISEASE; CASE REPORT; CELIAC DISEASE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HEPATITIS B; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; MALE; MEDICAL EXAMINATION; MULTIPLE CYCLE TREATMENT; REMISSION; SIBLING; T CELL LYMPHOMA; THERAPY EFFECT; TISSUE SECTION; TREATMENT OUTCOME; TREATMENT RESPONSE; ADJUVANT CHEMOTHERAPY; CANCER STAGING; CHEMISTRY; INTESTINE TUMOR; LARGE CELL LYMPHOMA; PATHOLOGY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; SECOND CANCER;

ADULT; CELIAC DISEASE; CHEMOTHERAPY, ADJUVANT; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL NEOPLASMS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; LYMPHOMA, T-CELL; MALE; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 34247601153     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000213391.49698.57     Document Type: Article

References (29)

1. Abruzzo LV, Griffith LM, Nandedkar M, et al. Histologically discordant lymphomas with B-cell and T-cell components. Am J Clin Pathol. 1997;108:316-323.
2. Allue L, Domingo A, Moreno A, et al. Simultaneous occurrence of cutaneous T cell lymphoma and low-grade B cell lymphoproliferative diseases. A report of two cases. J Am Acad Dermatol. 1990;23:677-681.
3. Barth TF, Bentz M, Leithauser F, et al. Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer. 2001;31:316-325.
4. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology. 2005;128:S79-S86.
5. Chott A, Dragosics B, Radaszkiewicz T. Peripheral T-cell lymphomas of the intestine. Am J Pathol. 1992;141:1361-1371.
6. Domizio P, Owen RA, Shepherd NA, et al. Primary lymphoma of the small intestine. A clinicopathological study of 119 cases. Am J Surg Pathol. 1993;17:429-442.
7. Farre C, Domingo-Domenech E, Font R, et al. Celiac disease and lymphoma risk: a multicentric case - control study in Spain. Dig Dis Sci. 2004;49:408-412.
8. Feldman AL, Berthold F, Arceci RJ, et al. Clonal relationship between precursor T-lymphoblastic leukaemia/lymphoma and Langerhans-cell histiocytosis. Lancet Oncol. 2005;6:435-437.
9. Franssila KO, Jaser N, Sivula A. Gastrointestinal non-Hodgkin's lymphoma. A population-based clinicopathological study of 111 adult cases with a follow-up of 10-15 years. APMIS. 1993;101:631-641.
10. Frolova EA, Richards SJ, Jones RA, et al. Immunophenotypic and DNA genotypic analysis of T-cell and NK-cell subpopulations in patients with B-cell chronic lymphocytic leukaemia (B-CLL). Leuk Lymphoma. 1995;16:307-318.
11. Gutierrez M, Chabner BA, Pearson D, et al. Role of a doxorubicin- containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH. J Clin Oncol. 2000;18:3633-3642.
12. Hoffenberg EJ, MacKenzie T, Barriga KJ, et al. A prospective study of the incidence of childhood celiac disease. J Pediatr. 2003;143:308-314.
13. Howell WM, Calder PC, Grimble RF. Gene polymorphisms, inflammatory diseases and cancer. Proc Nutr Soc. 2002;61:447-456.
14. Isaacson PG, Du MQ. Gastrointestinal lymphoma: where morphology meets molecular biology. J Pathol. 2005;205:255-274.
15. Jaffe ES, Harris NL, Stein H, et al. World Health Organization Classification of Tumors. Pathology & Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001.
16. Kim JH, Bang YJ, Park BJ, et al. Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res. 2002;93:471-477.
17. Kluin-Nelemans JC, Kester MG, Melenhorst JJ, et al. Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. Blood. 1996;87:3795-3802.
18. Kohno S, Ohshima K, Yoneda S, et al. Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology. 2003;43:135-143.
19. Liu YC, Tomashefski JF Jr, Cleveland RP, et al. Composite cutaneous T-cell lymphoma and small B-cell lymphocytic lymphoma: morphologic, immunologic, and molecular genetic documentation of concurrent lymph node involvement. Mod Pathol. 1994;7:641-646.
20. Magni M, Di Nicola M, Carlo-Stella C, et al. Identical rearrangement of immunoglobulin heavy chain gene in neoplastic Langerhans cells and B-lymphocytes: evidence for a common precursor. Leuk Res. 2002;26:1131-1133.
21. Martin-Subero JI, Siebert R, Harder L, et al. Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma. Am J Hematol. 2001;68:276-279.
22. Martinez A, Pittaluga S, Villamor N, et al. Clonal T-cell populations and increased risk for cytotoxic T-cell lymphomas in B-CLL patients: clinicopathologic observations and molecular analysis. Am J Surg Pathol. 2004;28:849-858.
23. Meijer JW, Mulder CJ, Goerres MG, et al. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand J Gastroenterol Suppl. 2004;241(Suppl):78-84.
24. Musolino C, Campo S, Pollicino T, et al. Evaluation of hepatitis B and C virus infections in patients with non-Hodgkin's lymphoma and without liver disease. Haematologica. 1996;81:162-164.
25. Nakamura S, Matsumoto T, Iida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97:2462-2473.
26. Newton R, Ferlay J, Beral V, et al. The epidemiology of non-Hodgkin's lymphoma: comparison of nodal and extra-nodal sites. Int J Cancer. 1997;72:923-930.
27. Polvi A, Maki M, Partanen J. Celiac patients predominantly inherit HLA-DPB1*0101 positive haplotype from HLA-DQ2 homozygous parent. Hum Immunol. 1997;53:156-158.
28. Smedby KE, Akerman M, Hildebrand H, et al. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut. 2005;54:54-59.
29. Sternberg SS. Diagnostic Surgical Pathology. Philadelphia: Lippincott Williams & Wilkins; 1999.